As reported in Renal Business Today: Spire Corp. has sold their catheter related business interest to Bard Access Systems for a cool $15 million. Bard Access Systems will also receive a license and a sublicense in the field of hemodialysis catheters to use certain intellectual property used by Spire in its Surface Treatment Business, which provides coating and surface modification services primarily to medical device customers.
That sounds like a sizeable sum to me...
0 comments:
Post a Comment